Rapid Micro Biosystems, Inc. (RPID) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
RPID EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RPID Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 22.7% | -141.1% | -140.3% |
| 2024 | -0.4% | -178.0% | -167.2% |
| 2023 | -24.4% | -251.2% | -233.0% |
| 2022 | -49.8% | -369.0% | -354.9% |
| 2021 | -33.3% | -203.3% | -316.5% |
Download Data
Export RPID earnings history in CSV or JSON format
Free sign-in required to download data
Rapid Micro Biosystems, Inc. (RPID) Earnings Overview
As of May 8, 2026, Rapid Micro Biosystems, Inc. (RPID) reported trailing twelve-month net income of -$44M, reflecting +2.8% year-over-year growth. The company earned $-0.99 per diluted share over the past four quarters, with a net profit margin of -140.3%.
Looking at the long-term picture, RPID's historical earnings data spans multiple years. The company achieved its highest annual net income of -$21M in fiscal 2019.
Rapid Micro Biosystems, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IDXX ($1.10B net income, 24.6% margin), NEOG (-$603M net income, -122.1% margin), BRKR (-$12M net income, -0.3% margin), RPID has room to improve margins relative to the peer group. Compare RPID vs IDXX →
RPID Earnings vs Peers
Earnings metrics vs comparable public companies
RPID Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$47M | -0.5% | -$47M | $-1.05 | -140.3% | -141.1% |
| 2024 | -$47M | +10.6% | -$50M | $-1.08 | -167.2% | -178.0% |
| 2023 | -$52M | +13.7% | -$57M | $-1.22 | -233.0% | -251.2% |
| 2022 | -$61M | +17.3% | -$63M | $-1.43 | -354.9% | -369.0% |
| 2021 | -$74M | -98.3% | -$47M | $-1.88 | -316.5% | -203.3% |
| 2020 | -$37M | -75.1% | -$31M | $-1.17 | -230.6% | -190.0% |
| 2019 | -$21M | - | -$19M | $-0.53 | -128.2% | -112.9% |
See RPID's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RPID Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RPID vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRPID — Frequently Asked Questions
Quick answers to the most common questions about buying RPID stock.
Is RPID growing earnings?
RPID EPS of $-0.99 reflects slowing growth at +2.8%, below the 5-year CAGR of N/A. TTM net income is $-44M. Expansion rate has moderated.
What are RPID's profit margins?
Rapid Micro Biosystems, Inc. net margin is -140.3%, with operating margin at -141.1%. Below-average margins reflect competitive or cost pressures.
How consistent are RPID's earnings?
RPID earnings data spans 2019-2025. The current earnings trend is +2.8% YoY. Historical data enables comparison across business cycles.